Abstract
Inasmuch as smooth muscle contractile protein abnormalities may account for the maintenance of a high pulmonary vascular resistance, we evaluated the pulmonary arterial myosin light chain kinase (MLCK) and phosphatase (MLCP) in normal and pulmonary hypertensive (PH) fetal sheep. In addition, aorta and vena cava MLCP and MLCK activities were also measured. The MLCK activity(nanomoles/min/mg) was determined by the incorporation of[32P]PO4-3 to the 20-kD smooth muscle myosin light chains and the MLCP activity by assaying for the dephosphorylation of the 20-kD myosin light chain (MLCP-light chain) and heavy meromyosin (MLCP-HMM). The MLCP content was determined by Western blot analysis. PH was characterized by a significant increase in the right-to-left ventricular wall weight ratio from 0.99 ± 0.04 in the control to 1.52 ± 0.12 in the experimental group (p < 0.01). The pulmonary MLCP-light chain and MLCP-HMM activities in the experimental group were 2.0 ± 0.2 and 1.3 ± 0.2 and significantly lower than in the control group values (3.8 ± 0.5 and 2.5 ± 0.3; p < 0.01). The MLCK activity was 9.6± 1.2 in the control and 7.8 ± 0.7 in the experimental fetal pulmonary artery (p = NS). The activities of both enzymes in the aorta and vena cava samples were not altered by PH. The MLCP content in experimental animals (0.50 ± 0.09 OD × mm2) was significantly lower than that for the control pulmonary tissue (1.72 ± 0.42; p < 0.01), suggesting that PH down-regulates pulmonary vascular MLCP expression. In conclusion, the maintenance of a high pulmonary vascular resistance in PH may be secondary to abnormalities in tissue content and/or activity of MLCP.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- PPHN:
-
persistent pulmonary hypertension syndrome of newborn
- MLCK:
-
myosin light chain kinase
- MLCP:
-
myosin light chain phosphatase
- HMM:
-
heavy meromyosin
- PP1:
-
PP2, protein phosphatase types 1 and 2
- PP1M:
-
myosin protein phosphatase
- SMP:
-
smooth muscle phosphatase
References
Walsh-Sukis MC 1993 Persistent pulmonary hypertension of the newborn. The black box revisited. Clin Perinatol 20: 127–143
Roberts JD, Polaner DM, Lang P, Zapol WM 1992 Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 818–819
Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH 1993 Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low dose of inhaled nitric oxide. J Pediatr 123: 103–108
Kinsella JP, Abman SH 1995 Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 126: 853–864
Levin DL, Mills LJ, Parkey M, Garriott J, Campbell W 1979 Constriction of the fetal ductus arteriosus after administration of indomethacin to the pregnant ewe. J Pediatr 94: 647–650
Abman SH, Shanley PF, Accurso FJ 1989 Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs. J Clin Invest 83: 1849–1858
Morin FC, Egan EA 1989 The effect of closing the ductus arteriosus on the pulmonary circulation of the fetal sheep. J Dev Physiol 11: 283–284
Belik J, Halayko AJ, Rao K, Stephen N 1993 Fetal ductus arteriosus ligation. Circ Res 72: 588–596
McQueston JA, Kinsella JP, Ivy DD, McMurtry IF, Abman SH 1995 Chronic pulmonary hypertension in utero impairs endothelium-dependent vasodilation. Am J Physiol 268:H288–H294
Ivy DD, Ziegler JW, Dubus MF, Fox JJ, Kinsella JP, Abman SH 1996 Chronic intrauterine pulmonary hypertension alters endothelin receptor activity in the ovine fetal lung. Pediatr Res 39: 435–442
Steinhorn RH, Russell JA, Morin FC 3 1995 Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension. Am J Physiol 268:H1483–H1489
Belik J, Keeley FW, Baldwin F, Rabinovitch M 1994 Pulmonary hypertension and vascular remodelling in fetal sheep. Am J Physiol 266:H2303–H2309
Bradford M 1976 A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principles of dye bindings. Anal Biochem 72: 248–254
Pato MD, Lye SJ, Kerc E 1991 Purification and characterization of pregnant sheep myometrium myosin light chain kinase. Arch Biochem Biophys 287: 24–32
Tulloch AG, Pato MD 1991 Turkey gizzard SMP-III is a novel protein phosphatase. J Biol Chem 266: 20168–20174
Towbin HS, Gordon J 1979 Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350–4354
Walsh MP 1994 Regulation of vascular smooth muscle tone. Can J Physiol Pharmacol 72: 919–936
Pato MD, Tulloch AG, Walsh MP, Kerc E 1994 Smooth muscle phosphatase: structure, regulation and function. Can J Physiol Pharmacol 72: 1427–1433
Pato MD, Kerc E 1990 Comparison of the properties of the protein phosphatases from avian and mammalian smooth muscles: purification and characterization of rabbit uterine smooth muscle phosphatases. Arch Biochem Biophys 276: 116–124
Alessi D, MacDougall LK, Sola MM, Ikebe M, Cohen P 1992 The control of protein phosphatase 1 by targeting subunit. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase 1. Eur J Biochem 210: 1023–1035
Okubo S, Ito M, Takashiba Y, Ichikawa Miyahara M, Shimuzu H, Konishi T, Shima H, Nagao M, Hartshorne D J, Nakano T 1994 A regulatory subunit of smooth muscle myosin bound phosphatase. Biochem Biophys Res Commun 200: 429–434
Hoar PE, Pato MD, Kerrick GL 1985 Myosin light chain phosphatase. Effect on the activation and relaxation of gizzard smooth muscle skinned fibers. J Biol Chem 260: 8760–8764
Sward K, Pato MD, Nilsson B, Nordstram I, Helstrand P 1995 Polyamines inhibit myosin phosphatase and increase LC20 phosphorylation and force in smooth muscle. Am J Physiol 269:C563–C571
Bialojan C, Merkel L, Ruegg JC, Gifford D, Di Salvo J 1985 Prolonged relaxation of detergent skinned smooth muscle involves decreased endogenous phosphatase activity. Proc Soc Exp Biol Med 178: 648–52
Haeberle JR, Hathaway DR, De Paoli-Roach AA 1985 Dephosphorylation of myosin by the catalytic subunit of a type 2 phosphatase produces relaxation of a chemically skinned uterine smooth muscle. J Biol Chem 260: 9965–9968
Bialojan C, Ruegg JC, Di Salvo J 1985 Phosphatase-mediated modulation of actinmyosin interaction in bovine aortic actomyosin and skinned porcine carotid artery. Proc Soc Exp Biol Med 178: 36–45
Smith PG, Tokui T, Ikebe M 1995 Mechanical strain increases contractile enzyme activity in cultured airway smooth muscle cells. Am J Physiol 268:L999–L1005
Vescovo G, Scannapieco G, Spano E, Calliari I, Leprotti C, Serafini F, Ambrosio GB, Dalla Libera L 1996 Myosin light chain kinase in vascular smooth muscle: an immunohistochemical study in normotensive and spontaneously hypertensive rats. Basic Appl Myol 6: 183–187
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Belik, J., Majumdar, R., Fabris, V. et al. Myosin Light Chain Phosphatase and Kinase Abnormalities in Fetal Sheep Pulmonary Hypertension. Pediatr Res 43, 57–61 (1998). https://doi.org/10.1203/00006450-199801000-00009
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199801000-00009
This article is cited by
-
T18/S19 diphosphorylation of myosin regulatory light chain impairs pulmonary artery relaxation in monocrotaline-induced pulmonary hypertensive rats
Pflügers Archiv - European Journal of Physiology (2023)
